Brain-computer interface commercialization accelerates, institutions closely follow brain-computer interface concept stocks
The commercialization of brain-computer interfaces (BCIs) is accelerating, drawing significant attention from institutional investors. In China's A-share market, 35 companies are involved in the BCI industry chain, with many experiencing a downturn in May, though some like Darui Electronics and Guangpu Co. have seen substantial gains. A notable portion of these companies have received positive ratings from institutional investors, with several securing over ten such ratings. AI
IMPACT Investor focus on BCI companies signals potential for increased funding and development in the neurotechnology sector.